These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 36948847)

  • 1. [Excerpt from the 2022 American Association for the Study of Liver Diseases clinical practice guideline: management of primary sclerosing cholangitis and cholangiocarcinoma].
    Yuan J; Han GH
    Zhonghua Gan Zang Bing Za Zhi; 2023 Jan; 31(1):35-41. PubMed ID: 36948847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management.
    Eaton JE; Talwalkar JA; Lazaridis KN; Gores GJ; Lindor KD
    Gastroenterology; 2013 Sep; 145(3):521-36. PubMed ID: 23827861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatobiliary complications of inflammatory bowel disease.
    Lichtenstein DR
    Curr Gastroenterol Rep; 2011 Oct; 13(5):495-505. PubMed ID: 21773706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical clues to suspicion of IgG4-associated sclerosing cholangitis disguised as primary sclerosing cholangitis or hilar cholangiocarcinoma.
    Oh HC; Kim MH; Lee KT; Lee JK; Moon SH; Song TJ; Eum J; Park DH; Lee SS; Seo DW; Lee SK
    J Gastroenterol Hepatol; 2010 Dec; 25(12):1831-7. PubMed ID: 21091993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholangiocarcinoma: Diagnosis and Management.
    Buckholz AP; Brown RS
    Clin Liver Dis; 2020 Aug; 24(3):421-436. PubMed ID: 32620281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective surveillance for cholangiocarcinoma in unselected individuals with primary sclerosing cholangitis.
    Villard C; Friis-Liby I; Rorsman F; Said K; Warnqvist A; Cornillet M; Kechagias S; Nyhlin N; Werner M; Janczewska I; Hagström T; Nilsson E; Bergquist A
    J Hepatol; 2023 Mar; 78(3):604-613. PubMed ID: 36410555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Characteristics, Associated Malignancies and Management of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients: A Multicentre Retrospective Cohort Study.
    Guerra I; Bujanda L; Castro J; Merino O; Tosca J; Camps B; Gutiérrez A; Gordillo Ábalos J; de Castro L; Iborra M; Carbajo AY; Taxonera C; Rodríguez-Lago I; Mesonero F; de Francisco R; Gómez-Gómez GJ; Chaparro M; Tardillo CA; Rivero M; Algaba A; Martín Arranz E; Cañete F; Vicente R; Sicilia B; Antolín B; Prieto V; Márquez L; Benítez JM; Camo P; Piqueras M; Gargallo CJ; Hinojosa E; Huguet JM; Pérez Calle JL; Van Domselaar M; Rodriguez C; Calvet X; Muñoz-Villafranca C; García-Sepulcre MF; Munoz-Garrido P; Fernández-Clotet A; Gómez Irwin L; Hernández S; Guardiola J; Sempere L; González Muñoza C; Hernández V; Beltrán B; Barrio J; Alba C; Moraleja I; López-Sanromán A; Riestra S; Martínez Montiel P; Garre A; Arranz L; García MJ; Martín Arranz MD; Corsino P; Arias L; Fernández-Salazar L; Fernández-Pordomingo A; Andreu M; Iglesias E; Ber Y; Mena R; Arroyo Villarino MT; Mora M; Ruiz L; López-Serrano P; Blazquez I; Villoria A; Fernández M; Bermejo F; Banales JM; Domènech E; Gisbert JP;
    J Crohns Colitis; 2019 Dec; 13(12):1492-1500. PubMed ID: 31063540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and management of cholangiocarcinoma in primary sclerosing cholangitis.
    Ahrendt SA; Pitt HA; Nakeeb A; Klein AS; Lillemoe KD; Kalloo AN; Cameron JL
    J Gastrointest Surg; 1999; 3(4):357-67; discussion 367-8. PubMed ID: 10482687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary sclerosing cholangitis.
    Milkiewicz P; Wunsch E
    Recent Results Cancer Res; 2011; 185():117-33. PubMed ID: 21822823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AGA Clinical Practice Update on Surveillance for Hepatobiliary Cancers in Patients With Primary Sclerosing Cholangitis: Expert Review.
    Bowlus CL; Lim JK; Lindor KD
    Clin Gastroenterol Hepatol; 2019 Nov; 17(12):2416-2422. PubMed ID: 31306801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-invasive diagnosis and follow-up of primary sclerosing cholangitis.
    Chazouillères O; Potier P; Bouzbib C; Hanslik B; Heurgue A; NGuyen-Khac E; Gournay J; Tanne F; Bureau C; Bourlière M; Ganne-Carrié N; de Lédinghen V
    Clin Res Hepatol Gastroenterol; 2022 Jan; 46(1):101775. PubMed ID: 34332142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reporting standards for primary sclerosing cholangitis using MRI and MR cholangiopancreatography: guidelines from MR Working Group of the International Primary Sclerosing Cholangitis Study Group.
    Venkatesh SK; Welle CL; Miller FH; Jhaveri K; Ringe KI; Eaton JE; Bungay H; Arrivé L; Ba-Ssalamah A; Grigoriadis A; Schramm C; Fulcher AS;
    Eur Radiol; 2022 Feb; 32(2):923-937. PubMed ID: 34363134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A contribution to the differential diagnostics of sclerosing cholangitides].
    Blaho M; Dítě P; Bojková M; Rydlo M; Kupka T; Svoboda P; Klvaňa P; Martínek A
    Vnitr Lek; 2017; 63(1):50-55. PubMed ID: 28225291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of trimodality sampling on detection of malignant biliary strictures compared with patients with primary sclerosing cholangitis.
    Baroud S; Sahakian AJ; Sawas T; Storm AC; Martin JA; Abu Dayyeh BK; Topazian MD; Levy MJ; Roberts LR; Gores GJ; Petersen BT; Chandrasekhara V
    Gastrointest Endosc; 2022 May; 95(5):884-892. PubMed ID: 34871554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of hepato-pancreato-biliary cancer is increased by primary sclerosing cholangitis in patients with inflammatory bowel disease: A population-based cohort study.
    Yu J; Refsum E; Helsingen LM; Folseraas T; Ploner A; Wieszczy P; Barua I; Jodal HC; Melum E; Løberg M; Blom J; Bretthauer M; Adami HO; Kalager M; Ye W
    United European Gastroenterol J; 2022 Mar; 10(2):212-224. PubMed ID: 35107865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in pre-liver transplant screening for cholangiocarcinoma among patients with primary sclerosing cholangitis.
    Trilianos P; Selaru F; Li Z; Gurakar A
    Digestion; 2014; 89(2):165-73. PubMed ID: 24577150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and clinical course of primary sclerosing cholangitis in France: a prospective cohort study.
    Garioud A; Seksik P; Chrétien Y; Corphechot C; Poupon R; Poupon RE; Chazouillères O
    Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):842-7. PubMed ID: 19779305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metal, magnet or transplant: options in primary sclerosing cholangitis with stricture.
    Ahmad J
    Hepatol Int; 2018 Nov; 12(6):510-519. PubMed ID: 30430358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Primary sclerosing cholangitis : Current diagnostics and treatment].
    Liwinski T; Schramm C
    Internist (Berl); 2018 Jun; 59(6):551-559. PubMed ID: 29700559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis (PSC): a Comprehensive Review.
    Song J; Li Y; Bowlus CL; Yang G; Leung PSC; Gershwin ME
    Clin Rev Allergy Immunol; 2020 Feb; 58(1):134-149. PubMed ID: 31463807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.